As part of our preparations for meeting with the U.S. Food and Drug Administration as part of its review of KRN23/burosumab, we've created an extremely brief survey about the most well-known symptoms of XLH.
The survey is just four questions and takes less than a minute. It will only be open for one week, until midnight on October 26, so don't miss out on this opportunity for your voice to be heard.
You'll find the survey here:
https://www.surveymonkey.com/r/VVM7ZXF
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.